Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?

Cancer research - 1 Sept 1997

Ursin G, Henderson B E, Haile R W, Pike M C, Zhou N, Diep A, Bernstein L

Abstract excerpt

We conducted a study to determine whether the risk of breast cancer associated with oral contraceptive (OC) use is higher in women with BRCA1/BRCA2 mutations than in other women by examining whether breast cancer patients with these mutations were more likely than breast cancer patients without m...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Breast Neoplasms
Share to BRCA1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Tumor Suppressor

Share to Heterozygote

Share to Mutation

Share to Risk Factors

Source

Identifiers

PMID: 9288771

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-9288771-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?PMID 9288771Read ↗

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).Semantic proximity Read ↗

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers.Semantic proximity Read ↗

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.Semantic proximity Read ↗

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.Semantic proximity Read ↗

Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.Semantic proximity Read ↗

BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.Semantic proximity Read ↗

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.Semantic proximity Read ↗

Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers.Semantic proximity Read ↗

Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.